BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23.03.2017

Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention." The purpose of this guidance is to assist sponsors in the clinical development of drugs for the prevention of delayed graft function (DGF) in kidney transplantation.

Source: Federal Register — Food and Drug AdministrationOpen original release →